March 2018 FDA Recall E-z-paste by Bracco Diagnostics Inc.
D-0609-2018 - Failed stability specifications

This Class II drug recall was voluntarily initiated by Bracco Diagnostics Inc. on March 8, 2018 for the product E-z-paste. The FDA reported the reason for recall as failed stability specifications. The product was distributed in Product was distributed throughout the United States, Hong Kong and New Zealand. and the recall is currently terminated.

Recall Number: D-0609-2018

Reason for Recall
Failed stability specifications: Out-of-specification (OOS) result for a preservative assay - methylparaben - during stability testing of one lot.
Initiated
03-08-2018
Reported
04-04-2018
Quantity
2,136 tubes

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Bracco Diagnostics Inc.
Product was distributed throughout the United States, Hong Kong and New Zealand.
E-Z-Paste Barium Sulfate Esophageal Cream (60% w/w), 454 g tube, Rx only, Manufactured by E-Z-EM Canada Inc. for E-Z-EM Inc. a subsidiary of Bracco Diagnostics Inc., Monroe Twp., NJ 0883, NDC 32909-770-01

Batch or Lot Expiration Information

Lot# 00538529

Affected Packages Involved in this Recall